IRVINE, Calif.–(BUSINESS WIRE)–
“Allergan, Inc., (AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the first and only filler approved to temporarily correct age-related volume loss in the cheek area in adults over the age of 21. JUVÉDERM VOLUMA™ XC helps create a more youthful appearance to the face and provides natural-looking and long-lasting results up to two years with optimal treatment.”
Dr. Hamilton will be the first Facial Plastic Surgeon in the state and one of the first in the country to be trained and using Juvederm Voluma™ XC. He will be traveling to California in early November for formal training. Look for more details regarding Juvederm Voluma™ XC on our website soon.